<VariationArchive VariationID="182873" VariationName="NM_005359.6(SMAD4):c.1258_1259dup (p.Ala421fs)" VariationType="Duplication" Accession="VCV000182873" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2015-02-24" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="181040" VariationID="182873">
      <GeneList>
        <Gene Symbol="SMAD4" FullName="SMAD family member 4" GeneID="4089" HGNC_ID="HGNC:6770" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51030213" stop="51085042" display_start="51030213" display_stop="51085042" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48556582" stop="48611411" display_start="48556582" display_stop="48611411" Strand="+" />
          </Location>
          <OMIM>600993</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_005359.6(SMAD4):c.1258_1259dup (p.Ala421fs)</Name>
      <CanonicalSPDI>NC_000018.10:51067135:GCG:GCGCG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>18q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51067135" stop="51067136" display_start="51067135" display_stop="51067136" variantLength="2" positionVCF="51067135" referenceAlleleVCF="G" alternateAlleleVCF="GGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48593505" stop="48593506" display_start="48593505" display_stop="48593506" variantLength="2" positionVCF="48593505" referenceAlleleVCF="G" alternateAlleleVCF="GGC" />
      </Location>
      <ProteinChange>A421fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.5" sequenceAccession="NM_005359" sequenceVersion="5" change="c.1259_1260insCG">
            <Expression>NM_005359.5:c.1259_1260insCG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_318t1" sequenceAccession="LRG_318t1">
            <Expression>LRG_318t1:c.1258_1259dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_318p1" sequenceAccession="LRG_318p1" change="p.Ala421fs">
            <Expression>LRG_318p1:p.Ala421fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.51067137_51067138dup" Assembly="GRCh38">
            <Expression>NC_000018.10:g.51067137_51067138dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.48593507_48593508dup" Assembly="GRCh37">
            <Expression>NC_000018.9:g.48593507_48593508dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013013.2" sequenceAccession="NG_013013" sequenceVersion="2" change="g.104098_104099dup">
            <Expression>NG_013013.2:g.104098_104099dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.6" sequenceAccession="NM_005359" sequenceVersion="6" change="c.1258_1259dup" MANESelect="true">
            <Expression>NM_005359.6:c.1258_1259dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005350.1" sequenceAccession="NP_005350" sequenceVersion="1" change="p.Ala421fs">
            <Expression>NP_005350.1:p.Ala421fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_318" sequenceAccession="LRG_318">
            <Expression>LRG_318:g.104098_104099dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA299973" DB="ClinGen" />
        <XRef Type="rs" ID="730881956" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1258_1259dup (p.Ala421fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000160965" Version="1">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-08-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1258_1259dup (p.Ala421fs) AND Juvenile polyposis syndrome" Accession="RCV001052787" Version="5">
        <ClassifiedConditionList TraitSetID="65684">
          <ClassifiedCondition DB="MedGen" ID="C0345893">Juvenile polyposis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-02-24" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16152648</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16436638</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22810475</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="65684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55407" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis+syndrome/3939" DB="Genetic Alliance" />
                <XRef ID="MONDO:0017380" DB="MONDO" />
                <XRef ID="9273005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis juvenile intestinal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis familial of entire gastrointestinal tract</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PJI</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JIP</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">JPS</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3065" />
                <XRef ID="3065" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C0345893" DB="MedGen" />
              <XRef ID="MONDO:0017380" DB="MONDO" />
              <XRef Type="MIM" ID="174900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="377375" SubmissionDate="2015-02-05" DateLastUpdated="2015-02-24" DateCreated="2015-02-24">
        <ClinVarSubmissionID localKey="58671" />
        <ClinVarAccession Accession="SCV000211674" DateUpdated="2015-02-24" DateCreated="2015-02-24" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-08-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1259_1260insCG (aka c.1258_1259dupCG) mutation in the SMAD4 gene causes a frameshift starting with codon Alanine 421, changes this amino acid to a Valine residue and creates a premature Stop codon at position 16 of the new reading frame, denoted p.Ala421ValfsX16. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The normal sequence with the bases that are duplicated in braces is: TGGG{CG}TGCA. The variant is found in SMAD4 panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.A421VfsX16</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1259_1260insCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Neoplastic Syndromes, Hereditary</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0027672" Status="current" Type="CUI" />
            <XRef DB="MeSH" ID="D009386" Status="current" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GDX_AllTest_AllPolys_06102014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2382431" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="8856923|MedGen:C0345893" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001217013" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16152648</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16436638</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22810475</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 182873). This variant has not been reported in the literature in individuals affected with SMAD4-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala421Valfs*16) in the SMAD4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMAD4 are known to be pathogenic (PMID: 16152648, 16436638, 22810475).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.48593505_48593506insGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0345893" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2382431" TraitType="Disease" MappingType="XRef" MappingValue="C0345893" MappingRef="MedGen">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="377375" TraitType="Disease" MappingType="Name" MappingValue="Neoplastic Syndromes, Hereditary" MappingRef="Preferred">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

